BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 34540858)

  • 1. The Th17/IL-17 Axis and Kidney Diseases, With Focus on Lupus Nephritis.
    Paquissi FC; Abensur H
    Front Med (Lausanne); 2021; 8():654912. PubMed ID: 34540858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
    Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis.
    Paquissi FC
    Front Immunol; 2017; 8():1195. PubMed ID: 29033929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Cytokines Th1, Th2, and Th17 Expression Profiling in Active Lupus Nephritis-IV: From a Southern Chinese Han Population.
    Sigdel KR; Duan L; Wang Y; Hu W; Wang N; Sun Q; Liu Q; Liu X; Hou X; Cheng A; Shi G; Zhang Y
    Mediators Inflamm; 2016; 2016():4927530. PubMed ID: 27738386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune podocytes in the immune microenvironment of lupus nephritis (Review).
    Liu R; Wen X; Peng X; Zhao M; Mi L; Lei J; Xu K
    Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37711069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17C/IL-17 Receptor E Signaling in CD4
    Krohn S; Nies JF; Kapffer S; Schmidt T; Riedel JH; Kaffke A; Peters A; Borchers A; Steinmetz OM; Krebs CF; Turner JE; Brix SR; Paust HJ; Stahl RAK; Panzer U
    J Am Soc Nephrol; 2018 Apr; 29(4):1210-1222. PubMed ID: 29483158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractalkine mediates lymphocyte inflammation and tubulointerstitial lesions by modifying the Treg/Th17 balance in lupus-prone MRL/lpr mice.
    Fu D; Ma J; Gong Q; Senouthai S; Wang J; You Y; Pinhu L
    Am J Transl Res; 2020; 12(10):6170-6186. PubMed ID: 33194022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th-17 related regulatory network in the pathogenesis of Arab patients with systemic lupus erythematosus and lupus nephritis.
    AlFadhli S; AlFailakawi A; Ghanem AA
    Int J Rheum Dis; 2016 May; 19(5):512-20. PubMed ID: 25496163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupus mice derived mesenchymal stromal cells: Beneficial or detrimental on SLE disease outcome.
    Hosseini S; Mahmoudi M; Rezaieyazdi Z; Shapouri-Moghaddam A; Hosseinzadeh A; Arab FL; Tabasi NS; Esmaeili SA
    Int Immunopharmacol; 2024 Jan; 126():111306. PubMed ID: 38039717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
    Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
    Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated interleukin-25 and its association to Th2 cytokines in systemic lupus erythematosus with lupus nephritis.
    Selvaraja M; Abdullah M; Arip M; Chin VK; Shah A; Amin Nordin S
    PLoS One; 2019; 14(11):e0224707. PubMed ID: 31697750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.
    Summers SA; Odobasic D; Khouri MB; Steinmetz OM; Yang Y; Holdsworth SR; Kitching AR
    Clin Exp Immunol; 2014 Jun; 176(3):341-50. PubMed ID: 24528105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cells and IL-17 in lupus nephritis.
    Koga T; Ichinose K; Tsokos GC
    Clin Immunol; 2017 Dec; 185():95-99. PubMed ID: 27109641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-17 in systemic lupus erythematosus: A comprehensive review.
    Li D; Guo B; Wu H; Tan L; Chang C; Lu Q
    Autoimmunity; 2015; 48(6):353-61. PubMed ID: 25894789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis.
    Xing Q; Wang B; Su H; Cui J; Li J
    Rheumatol Int; 2012 Apr; 32(4):949-58. PubMed ID: 21243492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus.
    Lyu MA; Tang X; Khoury JD; Raso MG; Huang M; Zeng K; Nishimoto M; Ma H; Sadeghi T; Flowers CR; Parmar S
    Front Immunol; 2023; 14():1217121. PubMed ID: 37736101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus.
    Shah K; Lee WW; Lee SH; Kim SH; Kang SW; Craft J; Kang I
    Arthritis Res Ther; 2010; 12(2):R53. PubMed ID: 20334681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Th17-Targeted Therapy Effective in Systemic Lupus Erythematosus?
    Petrić M; Radić M
    Curr Issues Mol Biol; 2023 May; 45(5):4331-4343. PubMed ID: 37232744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th17 cells: A new target in kidney disease research.
    Zhang T; Huo H; Zhang Y; Tao J; Yang J; Rong X; Yang Y
    Int Rev Immunol; 2024 Mar; ():1-17. PubMed ID: 38439681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.